These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25134821)

  • 1. Methylome analysis identifies a Wilms tumor epigenetic biomarker detectable in blood.
    Charlton J; Williams RD; Weeks M; Sebire NJ; Popov S; Vujanic G; Mifsud W; Alcaide-German M; Butcher LM; Beck S; Pritchard-Jones K
    Genome Biol; 2014 Aug; 15(8):434. PubMed ID: 25134821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between long interspersed nuclear element-1 methylation levels and relapse in Wilms tumors.
    de Sá Pereira BM; Montalvão-de-Azevedo R; Faria PA; de Paula Silva N; Nicolau-Neto P; Maschietto M; de Camargo B; Soares Lima SC
    Clin Epigenetics; 2017; 9():128. PubMed ID: 29255497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of promoter hypomethylation and expression of p73 as a diagnostic and prognostic biomarker in Wilms' tumour.
    Song D; Yue L; Wu G; Ma S; Yang H; Liu Q; Zhang D; Xia Z; Jia J; Wang J
    J Clin Pathol; 2016 Jan; 69(1):12-8. PubMed ID: 26184366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation Statuses of H19DMR and KvDMR at WT2 in Wilms Tumors in Taiwan.
    Lu MY; Wang WC; Hou TC; Kuo CY; Lai YC
    Pathol Oncol Res; 2020 Oct; 26(4):2153-2159. PubMed ID: 32157637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors.
    Yuan E; Li CM; Yamashiro DJ; Kandel J; Thaker H; Murty VV; Tycko B
    Mol Cancer Res; 2005 Sep; 3(9):493-502. PubMed ID: 16179496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Origins of DNA methylation defects in Wilms tumors.
    Anvar Z; Acurzio B; Roma J; Cerrato F; Verde G
    Cancer Lett; 2019 Aug; 457():119-128. PubMed ID: 31103718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relaxation of IGF2 imprinting in Wilms tumours associated with specific changes in IGF2 methylation.
    Sullivan MJ; Taniguchi T; Jhee A; Kerr N; Reeve AE
    Oncogene; 1999 Dec; 18(52):7527-34. PubMed ID: 10602511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children's Oncology Group AREN18B5-Q.
    Murphy AJ; Cheng C; Williams J; Shaw TI; Pinto EM; Dieseldorff-Jones K; Brzezinski J; Renfro LA; Tornwall B; Huff V; Hong AL; Mullen EA; Crompton B; Dome JS; Fernandez CV; Geller JI; Ehrlich PF; Mulder H; Oak N; Maciezsek J; Jablonowski CM; Fleming AM; Pichavaram P; Morton CL; Easton J; Nichols KE; Clay MR; Santiago T; Zhang J; Yang J; Zambetti GP; Wang Z; Davidoff AM; Chen X
    Nat Commun; 2023 Dec; 14(1):8006. PubMed ID: 38110397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative diagnosis of clear cell sarcoma of the kidney by detection of BCOR internal tandem duplication in circulating tumor DNA.
    Ueno-Yokohata H; Okita H; Nakasato K; Hishiki T; Shirai R; Tsujimoto S; Osumi T; Yoshimura S; Yamada Y; Shioda Y; Kiyotani C; Terashima K; Miyazaki O; Matsumoto K; Kiyokawa N; Yoshioka T; Kato M
    Genes Chromosomes Cancer; 2018 Oct; 57(10):525-529. PubMed ID: 30126017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wilms tumor chromatin profiles highlight stem cell properties and a renal developmental network.
    Aiden AP; Rivera MN; Rheinbay E; Ku M; Coffman EJ; Truong TT; Vargas SO; Lander ES; Haber DA; Bernstein BE
    Cell Stem Cell; 2010 Jun; 6(6):591-602. PubMed ID: 20569696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephroblastoma (Wilms' tumor): a model system of aberrant renal development.
    Re GG; Hazen-Martin DJ; Sens DA; Garvin AJ
    Semin Diagn Pathol; 1994 May; 11(2):126-35. PubMed ID: 7809506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 11p15.5 epimutations in children with Wilms tumor and hepatoblastoma detected in peripheral blood.
    Fiala EM; Ortiz MV; Kennedy JA; Glodzik D; Fleischut MH; Duffy KA; Hathaway ER; Heaton T; Gerstle JT; Steinherz P; Shukla N; McNeer N; Tkachuk K; Bouvier N; Cadoo K; Carlo MI; Latham A; Dubard Gault M; Joseph V; Kemel Y; Kentsis A; Stadler Z; La Quaglia M; Papaemmanuil E; Friedman D; Ganguly A; Kung A; Offit K; Kalish JM; Walsh MF
    Cancer; 2020 Jul; 126(13):3114-3121. PubMed ID: 32320050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations between Histological and Array Comparative Genomic Hybridization Characterizations of Wilms Tumor.
    Chiang MR; Kuo CW; Wang WC; Hou TC; Kuo CY; Lu MY; Lai YC
    Pathol Oncol Res; 2019 Jul; 25(3):1199-1206. PubMed ID: 30671724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations between histological characterizations and methylation statuses of tumour suppressor genes in Wilms' tumours.
    Lai YC; Lu MY; Wang WC; Hou TC; Kuo CY
    Int J Exp Pathol; 2022 Jun; 103(3):121-128. PubMed ID: 35436013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression and promoter methylation of SIX2 gene in peripheral blood of pediatric patients with nephroblastoma].
    Song DJ; Yue LF; Yang HY; Jia XY; Zhang JJ; Xu YL; Guo F; Wang JX
    Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(24):1876-80. PubMed ID: 24124738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stratification of Wilms tumor by genetic and epigenetic analysis.
    Scott RH; Murray A; Baskcomb L; Turnbull C; Loveday C; Al-Saadi R; Williams R; Breatnach F; Gerrard M; Hale J; Kohler J; Lapunzina P; Levitt GA; Picton S; Pizer B; Ronghe MD; Traunecker H; Williams D; Kelsey A; Vujanic GM; Sebire NJ; Grundy P; Stiller CA; Pritchard-Jones K; Douglas J; Rahman N
    Oncotarget; 2012 Mar; 3(3):327-35. PubMed ID: 22470196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
    Charles AK; Brown KW; Berry PJ
    Am J Pathol; 1998 Sep; 153(3):991-1000. PubMed ID: 9736048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour.
    Astuti D; Latif F; Wagner K; Gentle D; Cooper WN; Catchpoole D; Grundy R; Ferguson-Smith AC; Maher ER
    Br J Cancer; 2005 Apr; 92(8):1574-80. PubMed ID: 15798773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of WT1 and 11p15 constitutional aberrations and phenotypic correlation in childhood Wilms tumour patients.
    Segers H; Kersseboom R; Alders M; Pieters R; Wagner A; van den Heuvel-Eibrink MM
    Eur J Cancer; 2012 Nov; 48(17):3249-56. PubMed ID: 22796116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A CTCF-binding silencer regulates the imprinted genes AWT1 and WT1-AS and exhibits sequential epigenetic defects during Wilms' tumourigenesis.
    Hancock AL; Brown KW; Moorwood K; Moon H; Holmgren C; Mardikar SH; Dallosso AR; Klenova E; Loukinov D; Ohlsson R; Lobanenkov VV; Malik K
    Hum Mol Genet; 2007 Feb; 16(3):343-54. PubMed ID: 17210670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.